Drug companies spend almost twice as much on marketing and promoting their products than on research and development, says a new study.
In their analysis of data from two market research companies, Marc-Andre Gagnon and Joel Lexchin of Toronto’s York University found that American drug companies spent US$57.5 billion on promotional activities in 2004.
By comparison, spending on industrial pharmaceutical research and development in the United States was $31.5 billion in the same year, according to a report by the National Science Foundation, which included public funding for industrial research.
The types of marketing included in the US$57.5 billion figure, compiled using data from market research companies IMS and CAM, included free samples, direct-to-consumer drug advertising, meetings between company representatives and doctors to promote products, e-mail promotions and direct mail, said the study.
More
No comments:
Post a Comment